Renaissance Technologies’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Renaissance Technologies’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-94,058	Closed	-$5.03M	–	3769
2016 Q1	$5.03M	Buy	+94,058	New	+$6.94M	0.01%	1619
2015 Q4	–	Sell	-310,458	Closed	-$36.5M	–	3636
2015 Q3	$36.5M	Buy	+310,458	New	+$40.5M	0.09%	279
2014 Q4	–	Sell	-109,358	Closed	-$2.68M	–	3347
2014 Q3	$2.68M	Sell	109,358 -98,220	-47%	-$2M	0.01%	1521
2014 Q2	$3.68M	Buy	207,578 +174,878	+535%	+$2.82M	0.01%	1404
2014 Q1	$654K	Sell	32,700 -73,100	-69%	-$1.42M	﹤0.01%	2247
2013 Q4	$1.77M	Buy	+105,800	New	+$1.46M	﹤0.01%	1811

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Renaissance Technologies's ANAC Position: Q2 2016 in Review

Renaissance Technologies sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 94,058 shares — an estimated $5.03M sold.

Renaissance Technologies first reported a position in ANAC in Q4 2013 and held it in 6 quarters. The position peaked at $36.5M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Renaissance Technologies reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Renaissance Technologies sold 94,058 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.03M.
Renaissance Technologies first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 6 quarters.
Renaissance Technologies's ANACOR PHARMACEUTICALS INC COM position peaked at $36.5M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.